Weight loss in patients receiving radical radiation therapy for head and neck cancer: a prospective study.
Thirty-one patients receiving radiation therapy for localized cancer of the head and neck areas were systematically assessed before, during, and after treatment. The pathogenesis of weight loss and its association with treatment morbidity and other determinants were sought. The serial data collected consisted of a food frequency questionnaire based on Canada's Food Guide, anthropometric measurements, 10 Linear Analogue Self Assessment questions on morbidity, and biochemical and hematological indices. Twenty of 31 patients (68%) lost over 5% of their presenting weight within one month after completing treatment. The mean weight loss was 10% and the range of weight loss in this group was 5.4 to 18.9%. Pretreatment dietary habits, serum albumin, absolute lymphocyte count, serum creatinine, creatinine height index, and anthropometric measurements did not predict for weight loss. However, weight loss can be predicted on the basis of field size and site irradiated. Treatment-related morbidity involving dysguesia, xerostomia, dysphagia of solids, and mouth pain was greater and of longer duration in patients with weight loss. The sequence of development of these symptoms during treatment and their duration provide a rational basis for the timing and methods of nutritional intervention in this patient population.
D000328:Adult; D000368:Aged; D001835:Body Weight; D003037:Cobalt Radioisotopes / Q000008:administration & dosage; D003680:Deglutition Disorders / Q000209:etiology; D004408:Dysgeusia / Q000209:etiology; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006801:Humans; D008875:Middle Aged; D010146:Pain; D011446:Prospective Studies; D011867:Radioisotope Teletherapy / Q000009:adverse effects*; D014987:Xerostomia / Q000209:etiology
D003037:Cobalt Radioisotopes